Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mylan NV (NASDAQ:MYL)

37.07
Delayed Data
As of Jan 20
 +0.12 / +0.32%
Today’s Change
33.60
Today|||52-Week Range
54.23
-2.83%
Year-to-Date

Today’s Trading

Previous close36.95
Today’s open36.93
Day’s range36.80 - 37.35
Volume3,587,008
Average volume (3 months)6,248,544
Market cap$19.8B
Dividend yield--
Data as of 4:00pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)-27.35%
Earnings growth (this year)+10.38%
Earnings growth (next 5 years)+7.03%
Revenue growth (last year)+21.91%
P/E ratio16.0
Price/Sales2.84
Price/Book1.87

Competitors

 Today’s
change
Today’s
% change
VRTXVertex Pharmaceutica...+0.46+0.57%
INCYIncyte Corp-0.31-0.26%
BMRNBiomarin Pharmaceuti...-1.53-1.78%
BAXBaxter International...-0.34-0.73%
Data as of 4:14pm ET, 01/20/2017

Financials

Next reporting dateMarch 2, 2017
EPS forecast (this quarter)$1.43
Annual revenue (last year)$9.5B
Annual profit (last year)$847.6M
Net profit margin8.95%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Executive Director
Heather M. Bresch
President &
Executive Director
Rajiv Malik
Corporate headquarters
Hatfield, Hertfordshire

Forecasts


Search for Jobs